Stock

Acrivon Therapeutics, Inc. ACRV

$1.61-3.30%

All stocks Create account to unlock

Overview

ACRV market data

Price History

ACRV price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for ACRV. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

3 captured

Acrivon Therapeutics To Highlight AP3 Platform For Pathway-Based Drug Discovery And Development At AACR D3 July 21-24 · Jul 21, 2026, 8:32 PM

8-K filing — Acrivon Therapeutics, Inc. (ACRV) · Jun 17, 2026, 9:28 PM

Acrivon Therapeutics Q1 EPS $(0.49) Beats $(0.53) Estimate · May 13, 2026, 8:24 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock